FDA Adverse Event Malfunction Summary report: N

ANALYTICAL E MODULE

MDR report key: 3101835 · Received May 9, 2013

Report

Report Number
1823260-2013-02833
Event Type
Malfunction
Date Received
May 9, 2013
Date of Event
March 15, 2013
Report Date
June 18, 2013
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K961481
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KS
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE PATIENT'S C-PEPTIDE RESULT OF 0.5 NG/ML, WHICH IS BELOW THE EXPECTED VALUE, CONFIRMS THE ELECSYS INSULIN RESULTS BELOW THE EXPECTED VALUES. THE PATIENT'S HIGH RESULTS FOR GLUCOSE AND HBA1C SUPPORT THE CLINICAL PICTURE OF RELATIVELY REDUCED INSULIN SECRETION. THE COMPETITOR'S RESULTS ARE LIKELY DUE TO CROSS-REACTIVITY WITH INSULIN ANALOGS USED IN TYPE 2 DIABETES THERAPY.

Additional Manufacturer Narrative · 1

THIS EVENT OCCURED IN (B)(6). NO INFORMATION WAS PROVIDED ON THE SPECIFIC PART NUMBER INVOLVED IN THIS EVENT.

Description of Event or Problem · 1

THE PATIENT ALLEGED THEY RECEIVED QUESTIONABLE INSULIN RESULTS ON THEIR E170 ANALYZER. DURING AN ALMOST NINE MONTH PERIOD, THE CUSTOMER ALLEGED THEY HAD 4-5 EVENTS. THE CUSTOMER PROVIDED DATA FOR ONE PATIENT WITH DISCREPANT RESULTS. THE PATIENT'S RESULT FROM THE E170 ANALYZER WAS 1.7 UU/ML. THE PATIENT'S SAMPLE WAS TESTED ON THE RIA METHOD AND THE RESULT WAS 49.7 UU/ML. THE PATIENT'S SAMPLE WAS TESTED ON A SIEMENS CENTAUR ANALYZER AND THE RESULT WAS 55.9 UU/ML. ALL THREE RESULTS WERE REPORTED OUTSIDE THE LABORATORY, WITH THE 49.7 RESULTS BEING REPORTED AS THE FINAL REPORT. THERE WERE NO ADVERSE EVENTS. THE INSULIN REAGENT LOT AND EXPIRATION DATE WERE NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
203241 ANALYTICAL E MODULE IMMUNOCHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1 030 YR